-+ 0.00%
-+ 0.00%
-+ 0.00%

J.P. Morgan Life Sciences Private Capital names Bruce N. Rogers venture partner

PUBT·08/19/2026 16:03:00
Listen to the news
J.P. Morgan Life Sciences Private Capital names Bruce N. Rogers venture partner
  • J.P. Morgan Asset Management named Bruce N. Rogers as venture partner at Life Sciences Private Capital.
  • Rogers is president and CEO of a precision immunology portfolio company focused on selectively targeting disease-driving T-cell populations.
  • He previously led Morphic Therapeutic, joining as chief scientific officer in 2016 and later serving as president through its USD 3.2 billion sale to Lilly.
  • Rogers later became senior vice president and CEO of Morphic at Lilly, overseeing portfolio and team integration.
  • Earlier roles included head of Neuro-Opportunities at Pfizer, following 16 years in medicinal chemistry at Pfizer and Pharmacia.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JP Morgan Asset Management Inc. published the original content used to generate this news brief on August 18, 2026, and is solely responsible for the information contained therein.